Bachem Shows Strong Growth in the First Half of 2025
Bubendorf, Switzerland--(Newsfile Corp. - July 24, 2025) - Ad hoc announcement pursuant to Art. 53 LR Media Release Bachem shows stron
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-07-24 1:14 AM EDT | Bachem Holding AG
Veteran Finance Executive Tim Gillespie, CFA, Joins Biosenta as Strategic Advisor
Ontario and Calgary, Alberta--(Newsfile Corp. - July 21, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that Tim Gillespie, CFA has joined the company as a strategic advisor. In this role, Mr. Gillespie will counsel Biosenta's executive team and board on financing, risk management and go-to-market strategy as the company scales production and commercialization of its Tri-Filler™ antimicrobial technology.
Biotechnology, Chemical, Household / Consumer / Cosmetics
2025-07-21 5:00 PM EDT | Biosenta Inc.
Telescope Innovations Presents Results of Third Fiscal Quarter 2025
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2025 (Q3). The Company generated revenues of $1.4 million during this period, and an adjusted EBITA loss of $0.1 million. Revenues were driven strongly b
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-07-16 3:00 PM EDT | Telescope Innovations Corp.